WO2018082117A1 - External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof - Google Patents

External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof Download PDF

Info

Publication number
WO2018082117A1
WO2018082117A1 PCT/CN2016/105803 CN2016105803W WO2018082117A1 WO 2018082117 A1 WO2018082117 A1 WO 2018082117A1 CN 2016105803 W CN2016105803 W CN 2016105803W WO 2018082117 A1 WO2018082117 A1 WO 2018082117A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
parts
skin care
care preparation
chinese medicine
Prior art date
Application number
PCT/CN2016/105803
Other languages
French (fr)
Chinese (zh)
Inventor
张丽云
Original Assignee
惠州市蕙薏美生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 惠州市蕙薏美生物科技有限公司 filed Critical 惠州市蕙薏美生物科技有限公司
Publication of WO2018082117A1 publication Critical patent/WO2018082117A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/33Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Definitions

  • the invention belongs to the field of cosmetic skin care, and particularly relates to a topical Chinese medicine composition having the function of removing red blood of the skin and a skin care preparation containing the traditional Chinese medicine composition.
  • the red blood is mostly caused by various damage factors.
  • the epidermal layer of the skin is free of capillaries.
  • the cell nutrition of the epidermis is mainly derived from the third layer of spine in the epidermal layer of our skin.
  • the capillaries of the dermis layer help the acanthocytes to provide nutrients, and expand spontaneously to form red blood.
  • Liquid nitrogen cryotherapy is mainly for the case of lighter telangiectasia. This method is not effective and may leave uneven spots. Photon therapy and laser therapy must be performed by highly specialized personnel to completely remove the expanding capillaries, damage the epidermal layer of the skin, and make the skin thin and sensitive. At the same time, if it is a scary body, it will cause a large area of redness damage. Scars are formed with pigmentation and skin damage.
  • the red bloodshot skin is damaged not only by the epidermis of the skin, but also by capillaries. Therefore, it is necessary to repair the damaged skin epidermis and repair the damaged capillaries at the same time to completely remove the red blood.
  • Most of the skin care products that are used to remove red blood cells are only for repairing the epidermis of the skin, and there are few skin care products for repairing capillaries, so most skin care products can not really solve the problem of red blood.
  • the technical problem to be solved by the present invention is to provide a natural mild and non-irritating herbal skin care preparation which is designed from the perspective of skin health, plant ingredients to assist skin health metabolism, balance skin oil and water ratio, and remove redness.
  • the skin as a whole will return to its original healthy and natural state without secondary damage to the skin. Users can use it themselves without professional intervention.
  • Different plant components Repair the damaged skin epidermis, repair damaged capillaries, remove red blood from the roots and do not recur.
  • the technical problem to be solved by the present invention is achieved by the following technical solutions:
  • a topical Chinese medicine composition having the function of removing red blood of skin comprising the following components by weight:
  • safflower can dredge blood stasis in the capillaries of the red bloodshot skin, relieve red blood erythema symptoms, and repair damaged capillaries.
  • Angelica polysaccharide can reduce the redness and swelling of red blood silk skin and increase the elasticity of damaged capillary wall by increasing the proliferation and differentiation of hematopoietic stem cells and improving the hematopoietic microenvironment.
  • Astragalus polysaccharides as biomacromolecules, exert different immunomodulatory activities. These immune regulation can regulate the inflammation of red blood skin, effectively alleviate the facial inflammation of red blood and reduce the discomfort of red blood skin wounds.
  • Ganoderma lucidum can also promote circulation and reduce facial pressure on red blood.
  • Centella asiatica has a significant role in repairing the epidermis and promotes collagen regeneration.
  • the active ingredient of Centella asiatica can accelerate the healing of wounds, can significantly increase the tensile strength of the tissue, promote keratinization, and stimulate the rapid growth of reticuloendothelial tissue, promote the expression of fibroblast growth factor protein, and repair the damaged table. Cortex.
  • a skin care preparation comprising the above-mentioned topical Chinese medicine composition, comprising the above-mentioned external Chinese medicine composition and skin care preparation.
  • the skin care formulation consists of the following weight percentage components:
  • the oligopeptide is at least one of oligopeptide-1, oligopeptide-3, oligopeptide-5, and oligopeptide-6.
  • Oligopeptides can be directly absorbed by the skin, enter the epidermal cells, repair damaged collagen fibers of red blood skin, enhance skin elasticity, and repair damaged epidermis. The smaller the molecular weight, the easier the oligopeptide penetrates into the skin and is absorbed by the skin.
  • the oligopeptide is preferably oligopeptide-1 in the present invention.
  • the ceramide is at least one of ceramide 1, ceramide 2, ceramide 3, and ceramide 6. Ceramide also has the effect of repairing the damaged epidermal layer of red blood cells.
  • the emulsifier is preferably sorbitan stearate, sorbitol laurate, sucrose coconut oil At least one of an acid ester, dicetyl phosphate, stearyl 2, stearyl 21, cetyl-10 phosphate.
  • These emulsifiers have a special HLB value, and the scientific proportion design can form a unique liquid crystal structure, and the external Chinese medicine composition is encapsulated to form a microcrystalline state.
  • the formed microcrystalline state has a good affinity with human cells, and can smoothly pass through the cell membrane to directly transport the wrapped external Chinese medicine composition to the inside of the cell, thereby improving the absorption efficiency and also contributing to the red bloodshot effect.
  • the sodium hyaluronate is preferably a small molecular weight sodium hyaluronate having different molecular weights, a medium molecular sodium hyaluronate or a high molecular weight sodium hyaluronate, which can be applied to different parts of the skin to promote skin health.
  • the skin care preparation is a cream, or an emulsion or a body lotion.
  • the invention starts from the most basic reason for the formation of red blood cells, scientifically matches the proportion of each traditional Chinese medicine component, and cooperates. Repairs the damaged epidermis of red blood skin, restores the natural barrier of the skin, and repairs the damaged capillaries of the red blood skin, which removes red blood from the roots. Safflower, Angelica, Astragalus, Ganoderma lucidum promote facial microcirculation, dredge blood stasis in damaged capillaries, reduce red blood is facial pressure, repair damaged capillaries. Centella asiatica has a significant role in repairing the epidermis, which promotes collagen regeneration and significantly increases the tensile strength of the tissue, thereby repairing the damaged epidermal layer.
  • Example 1 Example 2
  • Example 3 Weight percent Weight percent / Weight 100 Components
  • Ratio /% to % ratio /% oligopeptide -1 0.1 0 0
  • Oligopeptide oligopeptide -2 0 2.5 0
  • the 100% cream preparation process is as follows:
  • Aqueous phase water, allantoin, ceramide, butanediol, glycerol, oligopeptide, sodium hyaluronate, topical Chinese medicine composition
  • Oil phase lecithin, emulsifier, safflower seed oil, jojoba oil (2) The formulation ratio of water was first added to the preparation vessel, and then the agitation was started, and allantoin, ceramide, butanediol, glycerin, oligopeptide, sodium hyaluronate were uniformly dispersed in water and stirred for 30 minutes.
  • 500 women with facial skin red blood between the ages of 14 and 55 years between 2012 and 2015 including 125 cases of hereditary red blood cells, stimulated by the external environment, such as chilling
  • the dry environment stimulated the skin to produce red blood in 125 cases, the use of inferior drugs and cosmetics caused by red blood in 125 cases, the use of hormone ointment caused by red blood in 125 cases.
  • the product is applied to the affected area of the skin, gently massaged until the skin is completely absorbed, and the skin surface is kept at least for 30 minutes after the massage. Continuous use for 60 days.
  • Hereditary telangiectasia 75 cases were cured, accounting for 60%; 38 cases were significant, accounting for 30.4%; 8 cases were effective, accounting for 6.4%; the effect was not obvious in 5 cases, accounting for 4%.
  • the external environment stimulated red blood 120 cases were cured, accounting for 96%; 5 cases were significant, accounting for 4%.
  • telangiectasia treatment hereditary, external environment, poor quality drugs and Caused by cosmetics, caused by hormone ointments.
  • the cream of the present invention has significant therapeutic and nourishing effects on red blood cells. Although the effects on various red blood cells are not balanced, the efficiency can be guaranteed above 90%.
  • 60 days is used in the test for the skin's two skin metabolic cycles, which lasts for a short period of time. If it lasts for half a year or a year, it is expected to have a better effect, ensuring that all types of red blood cells can be cured.
  • the various traditional Chinese medicine plant components selected by the invention are natural and non-toxic, and have good conditioning effect on human skin while removing red blood cells, and assist skin health.
  • the added skin nutrient provides skin nutrition from various angles, promotes skin skin thickening, restores skin's natural barrier, enhances resistance, and fundamentally treats red blood.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed are an external traditional Chinese medicine composition and a skin care preparation having the function of removing red blood in the skin, and a preparation method therefor. The external traditional Chinese medicine composition is made of safflower, Angelica sinensis, Radix astragali, Ganoderma lucidum, orange peel, Perilla frutescens, Centella asiatica, Smilax glabra, Atractylodes macrocephala, Opuntia dillenii haw and Rhizoma cimicifugae.

Description

具有祛除皮肤红血丝功能的外用中药组合物及其护肤制剂 技术领域  External Chinese medicine composition with skin red blood cell function and skin care preparation thereof
本发明属于化妆品护肤领域, 具体涉及一种具有祛除皮肤红血丝功能的外用 中药组合物及含有该中药组合物的护肤制剂。  The invention belongs to the field of cosmetic skin care, and particularly relates to a topical Chinese medicine composition having the function of removing red blood of the skin and a skin care preparation containing the traditional Chinese medicine composition.
背景技术 Background technique
面部红血丝的成因复杂多样, 主要包括原发性和继发性两种情况。 红血丝患 者面部看上去比一般正常肤色红, 人们常称为 "高原红"或 "红脸蛋"。 这种皮 肤薄而且敏感, 过冷、 过热、 情绪激动时脸色更红。 严重者还会形成沉积型色 斑, 不仅影响外表的美丽, 还会给心理造成阴影, 给正常生活带来极大的不便。  The causes of facial redness are complex and diverse, mainly including primary and secondary. People with red bloodshot eyes look redder than normal, which is often called "plateau red" or "red face". This skin is thin and sensitive, and it looks redder when it is too cold, overheated, and emotional. In severe cases, sedimentary stains will form, which not only affects the beauty of the appearance, but also creates a shadow on the mind, which brings great inconvenience to normal life.
红血丝大多是由各种损伤因素造成的, 皮肤的表皮层是没有毛细血管的, 表 皮层的细胞营养主要来源于我们皮肤表皮层的第三层棘层。 棘层细胞受损时, 自身供给营养能力下降, 而皮肤自身具备修复能力, 这时真皮层的毛细血管为 了帮助棘层细胞提供营养, 自主向上扩张, 从而形成红血丝。  The red blood is mostly caused by various damage factors. The epidermal layer of the skin is free of capillaries. The cell nutrition of the epidermis is mainly derived from the third layer of spine in the epidermal layer of our skin. When the acanthosis cells are damaged, the self-supplying ability is reduced, and the skin itself has the ability to repair. At this time, the capillaries of the dermis layer help the acanthocytes to provide nutrients, and expand spontaneously to form red blood.
目前, 处理面部毛细血管扩张的方法主要有液氮冷冻治疗、 光子治疗和激光 治疗。 液氮冷冻治疗主要针对毛细血管扩张较轻的情况, 此方法效果不彻底, 同时可能留下不均匀的斑点。 光子治疗和激光治疗必须要专业性很强的人员来 操作, 完全清除扩张的毛细血管, 伤害皮肤表皮层, 会使皮肤变薄敏感, 同时 如果是疤痕性体质, 会引起大面积发红损伤, 形成瘢痕, 并伴有色素沉着和肌 肤受损情况。  Currently, methods for treating facial telangiectasia include liquid nitrogen cryotherapy, photon therapy, and laser therapy. Liquid nitrogen cryotherapy is mainly for the case of lighter telangiectasia. This method is not effective and may leave uneven spots. Photon therapy and laser therapy must be performed by highly specialized personnel to completely remove the expanding capillaries, damage the epidermal layer of the skin, and make the skin thin and sensitive. At the same time, if it is a scary body, it will cause a large area of redness damage. Scars are formed with pigmentation and skin damage.
红血丝皮肤受损的不只是皮肤表皮层, 还有毛细血管, 所以完全修复红血丝 皮肤, 需要修复受损皮肤表皮层和修复受损毛细血管同时进行, 才能从根本上 去除红血丝。 市售用于祛除红血丝的护肤品, 多数只是修复皮肤表皮层, 很少 有修复毛细血管的护肤品, 所以多数护肤品不能真正解决红血丝问题。  The red bloodshot skin is damaged not only by the epidermis of the skin, but also by capillaries. Therefore, it is necessary to repair the damaged skin epidermis and repair the damaged capillaries at the same time to completely remove the red blood. Most of the skin care products that are used to remove red blood cells are only for repairing the epidermis of the skin, and there are few skin care products for repairing capillaries, so most skin care products can not really solve the problem of red blood.
发明内容 Summary of the invention
本发明所要解决的技术问题是提供一种天然温和无任何剌激性的草本护肤 制剂, 该护肤制剂从让皮肤健康角度设计配方, 植物成分辅助皮肤健康代谢, 平衡皮肤油和水比例, 祛除红血丝的同时, 皮肤整体会回到原来健康自然状态, 对皮肤没有二次伤害。 使用者可以自行使用无需专业人员操作。 不同植物成分 搭配修复受损皮肤表皮层, 修复受损毛细血管, 从根源上祛除红血丝不复发。 本发明所要解决的技术问题通过以下技术方案予以实现: The technical problem to be solved by the present invention is to provide a natural mild and non-irritating herbal skin care preparation which is designed from the perspective of skin health, plant ingredients to assist skin health metabolism, balance skin oil and water ratio, and remove redness. At the same time of bloodshot, the skin as a whole will return to its original healthy and natural state without secondary damage to the skin. Users can use it themselves without professional intervention. Different plant components Repair the damaged skin epidermis, repair damaged capillaries, remove red blood from the roots and do not recur. The technical problem to be solved by the present invention is achieved by the following technical solutions:
一种具有祛除皮肤红血丝功能的外用中药组合物, 由如下重量份配比的组分组 成: A topical Chinese medicine composition having the function of removing red blood of skin, comprising the following components by weight:
红花 20〜30份, 当归 20〜30份, 黄芪 10〜20份, 灵芝 20〜30份, 橙皮 5〜10 份, 紫苏 1〜10份, 积雪草 20〜50份, 土茯苓 0.5〜5份, 白术 0.1〜10份, 仙 人掌 5〜10份, 升麻 1〜10份。 20 to 30 servings of safflower, 20 to 30 parts of angelica, 10 to 20 parts of astragalus, 20 to 30 parts of Ganoderma lucidum, 5 to 10 parts of orange peel, 1 to 10 parts of perilla, 20 to 50 parts of Centella asiatica, soil mites 0.5 ~5 parts, 0.1 to 10 parts of Atractylodes, 5 to 10 parts of cactus, 1 to 10 parts of cohosh.
上述组合物中, 红花可以疏通红血丝皮肤扩张的毛细血管内的淤血, 缓解红 血丝红斑症状, 修复受损毛细血管。  In the above composition, safflower can dredge blood stasis in the capillaries of the red bloodshot skin, relieve red blood erythema symptoms, and repair damaged capillaries.
当归中含有的阿魏酸, 能够有效地抑制血小板的聚集。 同时当归多糖通过 增加造血干细胞的增殖分化和改善造血微环境, 缓解红血丝皮肤容易出现的爆 红发烫情况, 恢复受损毛细血管壁弹性。  The ferulic acid contained in Angelica can effectively inhibit the aggregation of platelets. At the same time, Angelica polysaccharide can reduce the redness and swelling of red blood silk skin and increase the elasticity of damaged capillary wall by increasing the proliferation and differentiation of hematopoietic stem cells and improving the hematopoietic microenvironment.
黄芪多糖作为生物大分子成分, 发挥着不同的免疫调节活性, 这些免疫调 节作用可以调理红血丝皮肤炎症情况, 有效缓解红血丝皮肤面部炎症, 减少红 血丝皮肤创面的不适感。  Astragalus polysaccharides, as biomacromolecules, exert different immunomodulatory activities. These immune regulation can regulate the inflammation of red blood skin, effectively alleviate the facial inflammation of red blood and reduce the discomfort of red blood skin wounds.
灵芝同样可以促进循环, 减轻红血丝皮肤面部压力。  Ganoderma lucidum can also promote circulation and reduce facial pressure on red blood.
积雪草修复表皮层作用显著, 可以促进胶原再生。 积雪草活性成分可以加 速伤口的愈合, 能显著提升组织的拉升强度, 促进角化, 并剌激网状内皮组织 的快速生长, 促进成纤维细胞生长因子蛋白的表达, 从而修复受损表皮层。  Centella asiatica has a significant role in repairing the epidermis and promotes collagen regeneration. The active ingredient of Centella asiatica can accelerate the healing of wounds, can significantly increase the tensile strength of the tissue, promote keratinization, and stimulate the rapid growth of reticuloendothelial tissue, promote the expression of fibroblast growth factor protein, and repair the damaged table. Cortex.
升麻, 白术, 土茯苓, 仙人掌中的活性成分, 具有保湿舒缓, 缓解敏感红血 丝皮肤炎症作用, 同时强化皮肤屏障, 修复皮肤表皮层, 抑制红血丝皮肤组胺 释放。  Cimicifuga, Atractylodes, earthworm, active ingredient in cactus, moisturizing and soothing, relieves the skin inflammation of sensitive red blood, strengthens skin barrier, repairs skin epidermis, and inhibits histamine release from red blood skin.
以上外用中药组合物, 每一种含有独特的植物活性成分, 科学搭配每一种成 分的比例, 协同作用。 从红血丝形成原因入手, 修复红血丝皮肤受损表皮层, 同时修复红血丝皮肤受损毛细血管, 不同植物成分针对红血丝皮肤不同症状, 彻底解决红血丝困扰。  The above-mentioned external Chinese medicine compositions, each containing a unique plant active ingredient, scientifically match the proportion of each component, and synergistically. Starting from the cause of red bloodshot formation, repairing the damaged epidermis of red blood silk skin, and repairing the damaged capillaries of red blood skin, different plant components for different symptoms of red blood skin, completely solve the problem of red blood.
进一步的, 所述外用中药组合物制备方法步骤如下:  Further, the steps of the preparation method of the external Chinese medicine composition are as follows:
( 1 ) 按上述配方所述的重量份配比称取原料药; ( 2) 将原料药放到水中煎煮水提两次, 第一次提取的原料药与水的重量比例 1 : 15〜1 :40,煎煮时间为 60〜180min,得到提取液,将第一次提取所得提取液滤出, 滤渣加入相对滤渣重量 20~60倍的水进行煎煮, 煎煮时间为 60〜120min得提取 液, 合并两次提取液得到外用中药组合物粗提物; (1) weighing the bulk drug according to the weight ratio described in the above formula; (2) Put the raw material in boiling water twice, the ratio of the first dose of the drug to water is 1: 15~1:40, the boiling time is 60~180min, and the extract is obtained. The extract obtained by one extraction is filtered out, and the filter residue is added to the water with a weight of 20 to 60 times relative to the weight of the filter residue for boiling, and the boiling time is 60 to 120 minutes to obtain an extract, and the two extracts are combined to obtain a crude extract of the external Chinese medicine composition;
( 3 ) 冷却粗提物到 22~28°C, 使用 100〜200目的滤布进行过滤, 得到的滤液, 即为外用中药组合物。  (3) The crude extract is cooled to 22 to 28 ° C, and filtered using a filter cloth of 100 to 200 mesh, and the obtained filtrate is a composition for external use.
一种含有上述外用中药组合物的护肤制剂, 由上述外用中药组合物和护肤品 辅料组成。  A skin care preparation comprising the above-mentioned topical Chinese medicine composition, comprising the above-mentioned external Chinese medicine composition and skin care preparation.
该护肤制剂由如下重量百分比的组分组成:  The skin care formulation consists of the following weight percentage components:
0.01〜5%的寡肽  0.01 to 5% of oligopeptide
0.1〜2%的尿囊素  0.1 to 2% of allantoin
0.01〜1%的神经酰胺  0.01~1% ceramide
1〜10%的丁二醇  1 to 10% butanediol
1〜5%的甘油  1 to 5% glycerin
0.5〜3%的卵磷脂  0.5 to 3% lecithin
1〜5%的乳化剂  1 to 5% emulsifier
0.01〜1%的透明质酸钠  0.01~1% sodium hyaluronate
5〜25%的外用中药组合物  5~25% topical Chinese medicine composition
2〜5%的红花籽油  2 to 5% of safflower seed oil
2〜5%的霍霍巴油  2 to 5% of jojoba oil
用水补充至 100%。  Add to 100% with water.
进一步的, 所述寡肽为寡肽 -1, 寡肽 -3, 寡肽 -5, 寡肽 -6 中的至少一种。 寡 肽可以直接被皮肤吸收, 进入表皮层细胞, 修复红血丝皮肤受损的胶原纤维, 增强皮肤弹性, 修复受损表皮层。 分子量越小的寡肽越容易渗透进入皮肤, 被 皮肤吸收, 本发明优选寡肽为寡肽 -1。  Further, the oligopeptide is at least one of oligopeptide-1, oligopeptide-3, oligopeptide-5, and oligopeptide-6. Oligopeptides can be directly absorbed by the skin, enter the epidermal cells, repair damaged collagen fibers of red blood skin, enhance skin elasticity, and repair damaged epidermis. The smaller the molecular weight, the easier the oligopeptide penetrates into the skin and is absorbed by the skin. The oligopeptide is preferably oligopeptide-1 in the present invention.
进一步的, 所述神经酰胺为, 神经酰胺 1, 神经酰胺 2, 神经酰胺 3, 神经酰 胺 6中的至少一种。 神经酰胺同样具有修复红血丝皮肤受损表皮层的作用。  Further, the ceramide is at least one of ceramide 1, ceramide 2, ceramide 3, and ceramide 6. Ceramide also has the effect of repairing the damaged epidermal layer of red blood cells.
进一步的, 所述的乳化剂优选山梨坦硬脂酸酯, 山梨醇月桂酸酯, 蔗糖椰油 酸酯, 二鲸蜡醇磷酸酯, 硬脂醇聚醚 2, 硬脂醇聚醚 21, 鲸蜡醇聚醚 -10磷酸酯 中的至少一种。 这些乳化剂因为具有特殊的 HLB值, 科学的比例设计可以形成 独特的液晶结构, 内包裹外用中药组合物, 形成微晶状态。 形成的微晶状态, 与人体细胞有很好的亲和性, 可以顺利的通过细胞膜, 将包裹的外用中药组合 物直接输送到细胞内部, 提高吸收效率, 同时也有助于去红血丝效果。 Further, the emulsifier is preferably sorbitan stearate, sorbitol laurate, sucrose coconut oil At least one of an acid ester, dicetyl phosphate, stearyl 2, stearyl 21, cetyl-10 phosphate. These emulsifiers have a special HLB value, and the scientific proportion design can form a unique liquid crystal structure, and the external Chinese medicine composition is encapsulated to form a microcrystalline state. The formed microcrystalline state has a good affinity with human cells, and can smoothly pass through the cell membrane to directly transport the wrapped external Chinese medicine composition to the inside of the cell, thereby improving the absorption efficiency and also contributing to the red bloodshot effect.
进一步的, 所述透明质酸钠, 优选不同分子量的小分子透明质酸钠, 中分子 透明质酸钠, 高分子透明质酸钠搭配使用, 可以作用到皮肤不同的部位, 促进 皮肤健康。  Further, the sodium hyaluronate is preferably a small molecular weight sodium hyaluronate having different molecular weights, a medium molecular sodium hyaluronate or a high molecular weight sodium hyaluronate, which can be applied to different parts of the skin to promote skin health.
进一步的, 所述护肤制剂为膏霜, 或乳液或润肤露。  Further, the skin care preparation is a cream, or an emulsion or a body lotion.
本发明具有如下有益效果:  The invention has the following beneficial effects:
本发明从红血丝形成最基本的原因入手, 科学搭配每一种中药成分的比例, 协 同作用。 修复红血丝皮肤受损表皮层, 恢复皮肤天然屏障, 同时修复红血丝皮 肤受损毛细血管, 从根本是去除红血丝。 红花, 当归, 黄芪, 灵芝 促进面部微 循环, 疏通受损毛细血管内的淤血, 减轻红血是皮肤面部压力, 修复受损毛细 血管。 积雪草修复表皮层作用显著, 可以促进胶原再生, 显著提升组织的拉升 强度, 从而修复受损表皮层。 升麻, 白术, 土茯苓, 仙人掌中的活性成分, 具 有保湿舒缓, 缓解敏感红血丝皮肤炎症作用, 同时强化皮肤屏障, 修复皮肤表 皮层, 抑制红血丝皮肤组胺释放, 彻底解决红血丝困扰。 The invention starts from the most basic reason for the formation of red blood cells, scientifically matches the proportion of each traditional Chinese medicine component, and cooperates. Repairs the damaged epidermis of red blood skin, restores the natural barrier of the skin, and repairs the damaged capillaries of the red blood skin, which removes red blood from the roots. Safflower, Angelica, Astragalus, Ganoderma lucidum promote facial microcirculation, dredge blood stasis in damaged capillaries, reduce red blood is facial pressure, repair damaged capillaries. Centella asiatica has a significant role in repairing the epidermis, which promotes collagen regeneration and significantly increases the tensile strength of the tissue, thereby repairing the damaged epidermal layer. Cimicifuga, Atractylodes, Earthworm, active ingredient in cactus, moisturizing and soothing, relieves the inflammatory effect of sensitive red blood cells, strengthens the skin barrier, repairs the skin surface layer, inhibits the release of histamine from red blood skin, and completely solves the problem of red blood.
具体实施方式 detailed description
下面结合实施例对本发明进行详细的说明, 实施例仅是本发明的优选实施 方式, 不是对本发明的限定。  The invention is described in detail below with reference to the embodiments, which are merely preferred embodiments of the invention, and are not intended to limit the invention.
外用中药组合物制备:  Preparation of topical Chinese medicine composition:
( 1 ) 按重量份数称取原料药: 红花 25份, 当归 25份, 黄芪 10份, 灵芝 20份, 橙皮 5份, 紫苏 3份, 积雪草 30份, 土茯苓 1份, 白术 0.1份, 仙人掌 (1) Weigh the raw materials by weight: 25 parts of safflower, 25 parts of angelica, 10 parts of astragalus, 20 parts of Ganoderma lucidum, 5 parts of orange peel, 3 parts of perilla, 30 parts of Centella asiatica, 1 part of earthworm, Atractylodes 0.1, Cactus
5份, 升麻 5份; 5 servings, 5 servings of cohosh;
(2)将原料药放到水中煎煮水提两次, 第一次提取的原料药与水的重量比 例 1 :40,煎煮时间为 180min,过滤之后得到提取液, 滤渣进行第二次提取,滤渣与 水的重量比例为 1 :30, 煎煮时间为 120min得提取液, 过滤得到第二次提取液, 合并两次提取液得到外用中药组合物粗提物; (2) Put the raw material medicine into the boiling water twice, the first weight ratio of the raw material medicine to water is 1:40, the boiling time is 180 minutes, the extract is obtained after filtration, and the filter residue is extracted for the second time. The weight ratio of the filter residue to the water is 1:30, the boiling time is 120 minutes to obtain an extract, and the second extraction liquid is obtained by filtration. Combining the two extracts to obtain a crude extract of the traditional Chinese medicine composition;
(3 ) 冷却粗提物到 25 °C, 使用 150目的滤布进行过滤, 得到的滤液, 即 为外用中药组合物。  (3) The crude extract was cooled to 25 ° C, and filtered using a 150-mesh filter cloth, and the obtained filtrate was a composition for external use.
表 1 : 实施例 1、 2、 3膏霜配方组成  Table 1: Example 1, 2, 3 cream formula composition
实施例 1 实施列 2 实施例 3 重量百分 重量百分 / 重量百 组分 组分  Example 1 Example 2 Example 3 Weight percent Weight percent / Weight 100 Components
比 /% 比% 分比 /% 寡肽 -1 0.1 0 0  Ratio /% to % ratio /% oligopeptide -1 0.1 0 0
寡肽 寡肽 -2 0 2.5 0  Oligopeptide oligopeptide -2 0 2.5 0
寡肽 -3 0 0 5  Oligopeptide -3 0 0 5
尿囊  Allantoin
尿囊素 1 0.1 2 神经酰胺 1 0.01 0 0  Allantoin 1 0.1 2 Ceramide 1 0.01 0 0
神经  Neural
神经酰胺 2 0 0.5 0  Ceramide 2 0 0.5 0
酰胺 Amide
神经酰胺 3 0 0 1 丁二  Ceramide 3 0 0 1
丁二醇 1 5 10 醇  Butanediol 1 5 10 alcohol
甘油 甘油 2.5 5 1 卵磷  Glycerin glycerol 2.5 5 1 egg phosphorus
卵磷脂 0.5 2.5 3  Lecithin 0.5 2.5 3
脂 山梨坦硬 Lipid
1.5 0 0  1.5 0 0
脂酸酯  Fatty acid ester
乳化 山梨醇月  Emulsified sorbitol month
1.5 0 0  1.5 0 0
剂 桂酸酯 Citrate
蔗糖椰油  Sucrose coconut oil
0 0 2.5 酸酯 二鲸蜡醇 0 0 2.5 acid ester Cetyl alcohol
0 0 2.5 磷酸酯  0 0 2.5 phosphate ester
硬脂醇聚  Stearyl alcohol
0 1.5 0  0 1.5 0
醚 2  Ether 2
硬脂醇聚  Stearyl alcohol
0 1.5 0  0 1.5 0
醚 21  Ether 21
小分子透  Small molecule
0.01 0.2 0  0.01 0.2 0
明质酸钠  Sodium hyaluronate
透明 中分子透  Transparent medium
0.05 0.3 0  0.05 0.3 0
质酸钠 明质酸钠 Sodium carbonate
高分子透  Polymer
0 0 1 明质酸钠  0 0 1 sodium sulphate
外用  External use
外用中药  Topical Chinese medicine
中药组合 10 5 25 Chinese medicine combination 10 5 25
组合物  combination
Object
红花  Safflower
红花籽油 2 3 5  Safflower oil 2 3 5
籽油 Seed oil
爱爱  Love love
佳佳  Jia Jia
霍霍巴油 5 3 2.5 巴油  Jojoba oil 5 3 2.5 bar oil
用水  Water
补 充 至 TolOO TolOO TolOOSupplement to TolOO TolOO TolOO
100% 膏霜制备工艺如下: The 100% cream preparation process is as follows:
( 1 ) 按每种组分水溶性特点分成水相和油相。  (1) Divided into an aqueous phase and an oil phase according to the water solubility characteristics of each component.
水相: 水, 尿囊素, 神经酰胺, 丁二醇, 甘油, 寡肽, 透明质酸钠, 外用 中药组合物  Aqueous phase: water, allantoin, ceramide, butanediol, glycerol, oligopeptide, sodium hyaluronate, topical Chinese medicine composition
油相: 卵磷脂, 乳化剂, 红花籽油, 霍霍巴油 (2) 在制备容器中先加入配方比例的水, 然后开启搅拌, 将尿囊素, 神经 酰胺, 丁二醇, 甘油, 寡肽, 透明质酸钠均匀地分散于水中, 搅拌 30min。 Oil phase: lecithin, emulsifier, safflower seed oil, jojoba oil (2) The formulation ratio of water was first added to the preparation vessel, and then the agitation was started, and allantoin, ceramide, butanediol, glycerin, oligopeptide, sodium hyaluronate were uniformly dispersed in water and stirred for 30 minutes.
(3 ) 搅拌 30min后, 开启加热, 温度不能超过 60°C, 搅拌 30min。  (3) After stirring for 30 minutes, turn on the heating, the temperature should not exceed 60 °C, and stir for 30 minutes.
(4) 将油相各组分混合均匀, 缓慢加热至 60°C, 搅拌均匀备用。  (4) Mix the oil phase components evenly, slowly heat to 60 ° C, stir well and set aside.
(5 ) 将油相加入到水相中, 开始乳化均质, 控制均质速度和温度, 温度不 要超过 60°C。  (5) Add the oil phase to the water phase, start emulsification homogenization, control the homogenization speed and temperature, and the temperature should not exceed 60 °C.
(6)持续乳化搅拌 20min后停止乳化, 继续搅拌降温至 25 °C时, 停止搅拌 出料。  (6) Continue emulsification and stirring for 20 minutes, then stop the emulsification. When stirring and cooling to 25 °C, stop stirring and discharge.
实施例 1的临床试验资料:  Clinical trial data of Example 1:
1.1受试对象:  1.1 Subjects:
按不同类型选择在 2012年至 2015年期间的 500例年龄在 14至 55岁之间 的女性面部皮肤红血丝患者, 其中, 遗传性红血丝 125例, 由外部环境剌激, 如爆冷暴热、 干燥环境剌激皮肤产生红血丝 125例, 使用劣质药物和化妆品引 起的红血丝 125例, 使用激素药膏引起的红血丝 125例。  According to different types, 500 women with facial skin red blood between the ages of 14 and 55 years between 2012 and 2015, including 125 cases of hereditary red blood cells, stimulated by the external environment, such as chilling The dry environment stimulated the skin to produce red blood in 125 cases, the use of inferior drugs and cosmetics caused by red blood in 125 cases, the use of hormone ointment caused by red blood in 125 cases.
1.2试验方法:  1.2 Test method:
患者每次清洁完皮肤之后, 使用该发明产品涂到皮肤对应患处, 轻柔按摩 至皮肤完全吸收, 按摩完之后至少要保持皮肤表面停留 30min。连续使用 60天。  Each time the patient cleans the skin, the product is applied to the affected area of the skin, gently massaged until the skin is completely absorbed, and the skin surface is kept at least for 30 minutes after the massage. Continuous use for 60 days.
1.3疗效判断:  1.3 judgment of efficacy:
红血丝全部消失者为痊愈, 消除 50%以上者为显著效果, 消除 30%以上者 为效果有效, 消除 30%以下者为效果不明显。  Those who have disappeared red blood are cured, and those who eliminate more than 50% have a significant effect. Those who eliminate more than 30% are effective, and those that eliminate 30% or less are not effective.
1.4试验结果:  1.4 test results:
遗传性毛细血管扩张: 痊愈 75例, 占 60%; 显著效果 38例, 占 30.4%; 有 效 8例, 占 6.4%; 效果不明显 5例, 占 4%。  Hereditary telangiectasia: 75 cases were cured, accounting for 60%; 38 cases were significant, accounting for 30.4%; 8 cases were effective, accounting for 6.4%; the effect was not obvious in 5 cases, accounting for 4%.
外部环境剌激红血丝: 痊愈 120例, 占 96%; 显著效果 5例, 占 4%。  The external environment stimulated red blood: 120 cases were cured, accounting for 96%; 5 cases were significant, accounting for 4%.
劣质药物和化妆品引起的毛细血管扩张: 痊愈 125例, 占 100%。  Capillary expansion caused by inferior drugs and cosmetics: 125 cases were cured, accounting for 100%.
激素药膏引起的红血丝: 痊愈 125例, 占 100%。  Red blood caused by hormonal ointment: 125 cases were cured, accounting for 100%.
1.5统计数据分析:  1.5 statistical data analysis:
毛细血管扩张治疗难易程度依次为: 遗传性, 外部环境剌激, 劣质药物和 化妆品引起, 激素药膏引起。 The difficulty of telangiectasia treatment is: hereditary, external environment, poor quality drugs and Caused by cosmetics, caused by hormone ointments.
1.6结论:  1.6 Conclusion:
上述临床试验表明, 本发明的膏霜对红血丝具有明显的治疗及调养作用。 虽然对各种红血丝效果不均衡, 但有效率可以保证 90%以上。 同时本试验中使 用 60天为皮肤两个皮肤代谢周期, 持续时间较短, 如果持续半年或一年, 预计 会有更好的效果, 保证所有类型的红血丝都可以痊愈。 同时, 本发明选用的各 种中药植物成分, 天然无毒, 在去除红血丝的同时对人体皮肤有很好的调理作 用, 辅助皮肤健康。 添加的皮肤营养剂, 可从各种角度提供皮肤营养, 促进皮 肤表皮层增厚, 恢复皮肤天然屏障, 抵抗力增强, 从根本上治疗红血丝。  The above clinical trials have shown that the cream of the present invention has significant therapeutic and nourishing effects on red blood cells. Although the effects on various red blood cells are not balanced, the efficiency can be guaranteed above 90%. At the same time, 60 days is used in the test for the skin's two skin metabolic cycles, which lasts for a short period of time. If it lasts for half a year or a year, it is expected to have a better effect, ensuring that all types of red blood cells can be cured. At the same time, the various traditional Chinese medicine plant components selected by the invention are natural and non-toxic, and have good conditioning effect on human skin while removing red blood cells, and assist skin health. The added skin nutrient provides skin nutrition from various angles, promotes skin skin thickening, restores skin's natural barrier, enhances resistance, and fundamentally treats red blood.
以上实施例仅表达了本发明的实施方式, 其描述较为具体和详细, 但不能 理解为对发明的限制, 但凡采用等同替换或等效变换的方式所获得的技术方案, 均应落在本发明的保护范围之内。  The above embodiments are only illustrative of the embodiments of the present invention, and the description thereof is more specific and detailed, but is not to be construed as limiting the invention, but the technical solutions obtained by means of equivalent substitution or equivalent transformation should fall within the present invention. Within the scope of protection.

Claims

权利要求书 Claim
1. 一种具有祛除皮肤红血丝功能的外用中药组合物, 其特征在于, 所述组合物 由如下重量份配比的组分组成: A topical Chinese medicine composition having a function of removing red blood cells from the skin, characterized in that the composition is composed of the following components by weight:
红花 20〜30份, 当归 20〜30份, 黄芪 10〜20份, 灵芝 20〜30份, 橙皮 5〜10 份, 紫苏 1〜10份, 积雪草 20〜50份, 土茯苓 0.5〜5份, 白术 0.1〜10份, 仙 人掌 5〜10份, 升麻 1〜10份。 20 to 30 servings of safflower, 20 to 30 parts of angelica, 10 to 20 parts of astragalus, 20 to 30 parts of Ganoderma lucidum, 5 to 10 parts of orange peel, 1 to 10 parts of perilla, 20 to 50 parts of Centella asiatica, soil mites 0.5 ~5 parts, 0.1 to 10 parts of Atractylodes, 5 to 10 parts of cactus, 1 to 10 parts of cohosh.
2. 一种如权利要求 1所述的具有祛除皮肤红血丝功能的外用中药组合物的制备 方法, 其特征在于, 步骤如下:  A method for preparing a topical Chinese medicine composition having the function of removing red blood of the skin according to claim 1, wherein the steps are as follows:
( 1 ) 按权利要求 1所述的重量份配比称取原料药;  (1) weighing the raw material according to the weight ratio according to claim 1;
( 2) 将原料药放到水中煎煮水提两次, 第一次提取的原料药与水的重量比例 1 : 15〜1 :40, 煎煮时间为 60〜180min, 得到提取液, 将第一次提取所得提取液滤 出, 滤渣加入相对滤渣重量 20~60倍的水进行煎煮, 煎煮时间为 60〜120min得 第二次提取液, 合并两次提取液得到外用中药组合物粗提物;  (2) Put the raw material in boiling water twice, the ratio of the first dose of the drug to water is 1: 15~1:40, the boiling time is 60~180min, and the extract is obtained. The extract obtained by one extraction is filtered out, and the filter residue is added to the water with a weight of 20 to 60 times relative to the weight of the filter residue for boiling. The boiling time is 60 to 120 minutes to obtain a second extract, and the two extracts are combined to obtain a crude extract of the traditional Chinese medicine composition. Object
( 3 ) 冷却粗提物到 22~28°C, 使用 100〜200目的滤布进行过滤, 得到的滤液, 即为外用中药组合物。  (3) The crude extract is cooled to 22 to 28 ° C, and filtered using a filter cloth of 100 to 200 mesh, and the obtained filtrate is a composition for external use.
3. 一种具有祛除皮肤红血丝功能的外用护肤制剂, 其特征在于, 所述护肤制剂 由权利要求 1所述的外用中药组合物和护肤品辅料组成。  A topical skin care preparation having a function of removing redness of the skin, characterized in that the skin care preparation comprises the external Chinese medicine composition according to claim 1 and a skin care preparation.
4. 一种如权利要求 3所述的具有祛除皮肤红血丝功能的外用护肤制剂, 其特征 在于, 所述护肤制剂由如下重量百分比的组分组成:  4. An external skin care preparation having a function of removing redness of the skin according to claim 3, wherein the skin care preparation is composed of the following components by weight:
0.01〜5%的寡肽  0.01 to 5% of oligopeptide
0.1〜2%的尿囊素 0.1 to 2% of allantoin
0.01〜1%的神经酰胺 0.01~1% ceramide
1〜10%的丁二醇  1 to 10% butanediol
1〜5%的甘油 1 to 5% glycerin
0.5〜3%的卵磷脂  0.5 to 3% lecithin
1〜5%的乳化剂 1 to 5% emulsifier
0.01〜1%的透明质酸钠 0.01~1% sodium hyaluronate
5〜25%的外用中药组合物 2〜5%的红花籽油 5~25% topical Chinese medicine composition 2 to 5% of safflower seed oil
2〜5%的霍霍巴油 2 to 5% of jojoba oil
用水补充至 100%。 Add to 100% with water.
5. 一种如权利要求 4所述的具有祛除皮肤红血丝功能的外用护肤制剂, 其特征 在于, 所述的寡肽为寡肽 -1, 寡肽 -3, 寡肽 -5, 寡肽 -6中的至少一种。 5. The external skin care preparation according to claim 4, wherein the oligopeptide is oligopeptide-1, oligopeptide-3, oligopeptide-5, oligopeptide- At least one of 6.
6. 一种如权利要求 4所述的具有祛除皮肤红血丝功能的外用护肤制剂, 其特征 在于, 所述的神经酰胺为, 神经酰胺 1, 神经酰胺 2, 神经酰胺 3, 神经酰胺 6 中的至少一种。 6. The external skin care preparation according to claim 4, wherein the ceramide is ceramide 1, ceramide 2, ceramide 3, ceramide 6 At least one.
7. 一种如权利要求 4所述的具有祛除皮肤红血丝功能的外用护肤制剂, 其特征 在于, 所述的乳化剂优选山梨坦硬脂酸酯, 山梨醇月桂酸酯, 蔗糖椰油酸酯, 二鲸蜡醇磷酸酯, 硬脂醇聚醚 2, 硬脂醇聚醚 21, 鲸蜡醇聚醚 -10磷酸酯中的至 少一种。 7. The external skin care preparation according to claim 4, wherein the emulsifier is preferably sorbitan stearate, sorbitol laurate, sucrose cocoate At least one of cetyl phosphate, stearyl 2, stearyl 21, cetyl-10 phosphate.
8. 一种如权利要求 4所述的具有祛除皮肤红血丝功能的外用护肤制剂, 其特征 在于所述护肤制剂为膏霜, 或乳液或润肤露。  A topical skin care preparation having the function of removing redness of the skin according to claim 4, wherein the skin care preparation is a cream, or an emulsion or a body lotion.
PCT/CN2016/105803 2016-11-03 2016-11-14 External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof WO2018082117A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610952013.8 2016-11-03
CN201610952013.8A CN106362053A (en) 2016-11-03 2016-11-03 Externally-applied traditional Chinese medicine composition with function of removing couperose skin and skin-care preparation of composition

Publications (1)

Publication Number Publication Date
WO2018082117A1 true WO2018082117A1 (en) 2018-05-11

Family

ID=57893466

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/105803 WO2018082117A1 (en) 2016-11-03 2016-11-14 External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof

Country Status (2)

Country Link
CN (1) CN106362053A (en)
WO (1) WO2018082117A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107320583A (en) * 2017-07-04 2017-11-07 合肥丰瑞隆生物科技有限公司 Eradicates is except external application Chinese medicine extract of red blood silk and preparation method thereof and external preparation
CN107375713A (en) * 2017-07-04 2017-11-24 合肥丰瑞隆生物科技有限公司 The Chinese medical extract and preparation method and external preparation of red blood silk effect are removed with Eradicates
CN109674890B (en) * 2019-01-17 2021-08-06 青海大学 Composition and skin care product for preventing and/or treating skin red blood streak and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000006A (en) * 2010-12-03 2011-04-06 北京工商大学 Skin care composite and preparation with function of eliminating facial redness and preparation methods thereof
CN103735440A (en) * 2013-12-08 2014-04-23 刘聪 Telangiectasis removing face cream
CN105055289A (en) * 2015-07-20 2015-11-18 毛春红 Multi-effect skin caring and smoothening traditional Chinese medicine lotion and preparation method thereof
CN105963178A (en) * 2016-05-15 2016-09-28 佛山市芊茹化妆品有限公司 Cosmetic composition with function of removing red blood streaks

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102935125B (en) * 2012-11-29 2013-11-20 北京工商大学 Externally applied Chinese herbal composition with facial redness removing effect, preparation and method for preparing externally applied Chinese herbal composition with facial redness removing effect
CN103948817B (en) * 2014-01-15 2017-01-11 北京工商大学 External application traditional Chinese medicine composition with effects of acne and comedo removing and telangiectasis relieving, and skin care preparation and preparation method thereof
CN105055575B (en) * 2015-08-24 2018-05-04 北京太和逸肤科技有限公司 There is external medicine composition, preparation of whitening lifting qi and blood and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000006A (en) * 2010-12-03 2011-04-06 北京工商大学 Skin care composite and preparation with function of eliminating facial redness and preparation methods thereof
CN103735440A (en) * 2013-12-08 2014-04-23 刘聪 Telangiectasis removing face cream
CN105055289A (en) * 2015-07-20 2015-11-18 毛春红 Multi-effect skin caring and smoothening traditional Chinese medicine lotion and preparation method thereof
CN105963178A (en) * 2016-05-15 2016-09-28 佛山市芊茹化妆品有限公司 Cosmetic composition with function of removing red blood streaks

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WANG, NING ET AL.: "The Application of Blood Stasis Theory in Clinical Treatment of Skin Disease", CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE, vol. 34, no. 11, 30 November 2014 (2014-11-30), pages 1379 *

Also Published As

Publication number Publication date
CN106362053A (en) 2017-02-01

Similar Documents

Publication Publication Date Title
CN105997836B (en) A kind of ferment shampoo and its preparation method
CN105769654B (en) A kind of Shu Min skin care compositions and its application in cosmetics
CN102091258B (en) Chinese medicinal composition for dispelling scars and preparation method thereof
CN106389219A (en) Externally-used traditional Chinese medicine composition with whitening and freckle removing functions and skin-care preparation
JP5646117B2 (en) Hair growth promoter and production method
CN104434618A (en) Nine-herb cream with effects of whitening and removing freckle marks and preparation method thereof
CN111529477A (en) Composition for caring hair, and preparation and application thereof
CN109044941B (en) Skin firming, nourishing and moisturizing composition and preparation method and application thereof
CN105342908A (en) Centella asiatica beauty and anti-wrinkle traditional Chinese medicinal ointment for relieving wrinkles and preparation method of traditional Chinese medicinal ointment
WO2018082117A1 (en) External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof
CN106511211B (en) Anti-inflammatory acne-removing skin-care lotion and preparation method thereof
CN105147577A (en) Toner capable of relieving melanin deposition and preparation method of toner
CN105055849B (en) Enriching yin Chinese medical extract for nourishing kidney and its preparation method and application
CN108186513A (en) A kind of face mask of traditional Chinese medicine and preparation method thereof
CN106994148A (en) A kind of anti acne of traditional Chinese medicine preparation
CN104414954A (en) Snail skin cream for relieving allergy
CN108066274B (en) Hair blackening compound and preparation method and application thereof
CN115227622A (en) Preparation process of hair loss preventing and nourishing essence
CN113599480A (en) Scraping oil for relieving hyperplasia of mammary glands symptoms and preparation method thereof
CN108403869B (en) Traditional Chinese medicine composition for removing chloasma and preparation method thereof
CN112603882A (en) Traditional Chinese medicine mask powder for removing freckles, whitening and removing jaundice and preparation method thereof
CN111789800A (en) Aloe composite repair factor and preparation method thereof
CN108403603A (en) A kind of cherry kaempferia galanga beauty treatment and eliminating spot natural traditional Chinese medicine face mask cream and preparation method thereof
CN109674890B (en) Composition and skin care product for preventing and/or treating skin red blood streak and preparation method thereof
CN113768803B (en) Composition of anti-hair loss and anti-dandruff spray and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16920533

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01.10.2019)

122 Ep: pct application non-entry in european phase

Ref document number: 16920533

Country of ref document: EP

Kind code of ref document: A1